Niagen Bioscience vs Natural Alternatives International
Niagen Bioscience and Natural Alternatives International are similar in size: $129m and $143m of revenue in their latest fiscal years. Niagen Bioscience grew faster (29.9% against 9.7%). Niagen Bioscience kept more of each dollar of sales as profit: a net margin of 13.4% against -14.5%.
| Latest fiscal year | Niagen BioscienceNAGE, 2025 | Natural Alternatives InternationalNAII, 2026 |
|---|---|---|
| Revenue | $129m | $143m |
| Revenue growth | 29.9% | 9.7% |
| Net income | $17.4m | −$20.7m |
| Operating margin | — | — |
| Net margin | 13.4% | -14.5% |
| Return on equity | 28.3% | -35.0% |
| Free cash flow | $13.5m | −$12.6m |
| Cash | $64.8m | $7.4m |
| Total debt | $0 | $18.0m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $251,000 | $89,000 |
| Employees | — | 219 |
| Market value | $185m | $6.7m |
| Price vs our value range | Within our value range | — |
| Moat score | 27 (Weak) | 27 (Weak) |
| Insider trades, 12 months | 2 buys, 0 sales | 14 buys, 0 sales |